Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The myocyte plasma membrane potential is the electrical voltage difference across the cell membrane of a muscle cell, mainly established by ionic concentration gradients (especially potassium, sodium, chloride, and calcium), selective permeability of ion channels, and activity of electrogenic pumps (Na⁺/K⁺-ATPase)[1][2][3][5]. In cardiac myocytes, the resting membrane potential is typically around −80 to −90 mV[2][3][8]. Changes in this voltage underlie the electrical activity that initiates muscle contraction through action potentials, and the maintenance of normal membrane potential is essential for proper muscle function, electrical conduction, and rhythmic contraction[1][8]. The membrane potential is a dynamic property, not a discrete protein or receptor, and cannot be targeted directly by therapeutics; instead, drugs modulate the activities of various ion channels and pumps that together define the membrane potential[4].
Drugs do not target the membrane potential directly; they alter ion channel activity to change the membrane potential
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane potential of myocyte plasma membrane (null).